Gastropanel for Gastric Atrophy and Cancer Risk Assessment
Gastropanel *for Early Detection of Gastric Atrophy and Gastric Cancer Risk
Sponsor: Biohit Healthcare Ltd
Listed as NCT02114411, this observational or N/A phase trial focuses on Gastritis, Atrophic and Stomach Neoplasms and remains ongoing. Sponsored by Biohit Healthcare Ltd, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jan 2017 — Feb 2018 [monthly]
Unknown Status NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Biohit Healthcare Ltd
For direct contact, visit the study record on ClinicalTrials.gov .